Insider Transactions

What Clearside Biomedical, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Thorp Clay	Director	Feb 24	Open-market buy · P	+15,000	$0.92	+$13.8K	176,141
Chong Ngai Hang Victor	Chief Medical Officer	Nov 01	Open-market buy · P	+36,500	$1.00	+$36.5K	100,000
Chong Ngai Hang Victor	Chief Medical Officer	Jun 24	Open-market buy · P	+23,500	$1.06	+$24.9K	63,500
Yerxa Benjamin R	Director	May 15	Open-market buy · P	+7,813	$1.31	+$10.2K	17,957
Gibney Anthony S	Director	Apr 18	Open-market buy · P	+93,290	$1.30	+$121K	100,000
Gibney Anthony S	Director	Apr 17	Open-market buy · P	+6,710	$1.25	+$8.39K	6,710
Chong Ngai Hang Victor	CHIEF MEDICAL OFFICER	Mar 20	Open-market buy · P	+30,000	$1.60	+$48K	30,000
Whitmore Bradford T	10% owner	Feb 07	Open-market buy · P	+444,444	$1.35	+$600K	4,495,034
Deignan Charles A.	Chief Financial Officer	Jan 19	Open-market sale · S	−12,900	$1.28	−$16.5K	384,662
Lasezkay George M	CEO	Jan 19	Open-market sale · S	−18,000	$1.27	−$22.9K	466,577
Whitmore Bradford T	10% owner	Nov 01	Open-market buy · P	+64,366	$0.74	+$47.9K	4,050,590
Whitmore Bradford T	10% owner	Oct 31	Open-market buy · P	+70,812	$0.73	+$51.5K	3,986,224
Whitmore Bradford T	10% owner	Oct 30	Open-market buy · P	+600	$0.69	+$411	3,915,412
Hutson Nancy J	Director	Oct 03	Open-market buy · P	+10,000	$0.86	+$8.6K	93,000
Thorp Clay	Director	Sep 25	Open-market buy · P	+10,000	$0.86	+$8.6K	40,522
Humphries William D.	Director	Sep 22	Exercise / conversion · M	+22,727	$0.40	+$9.09K	51,040
Deignan Charles A.	Chief Financial Officer	Sep 13	Exercise / conversion · M	+34,090	$0.40	+$13.6K	397,562
Ciulla Thomas	Chief Medical Officer	Jan 20	Disclosed 10b5-1 sale · S	−13,700	$1.47	−$20.1K	291,890
Deignan Charles A.	Chief Financial Officer	Jan 19	Disclosed 10b5-1 sale · S	−14,030	$1.50	−$21K	363,472
Lasezkay George M	CEO	Jan 19	Disclosed 10b5-1 sale · S	−20,030	$1.46	−$29.2K	484,577

Page 1 of 10 · showing the 20 most recent Sign up free to view all 187 transactions and filter by insider →

Comments